Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control.

Barchetta I, Guglielmi C, Bertoccini L, Calella D, Manfrini S, Secchi C, Pozzilli P, Cavallo MG; On behalf of the IMDIAB group.

Acta Diabetol. 2015 Feb 27. [Epub ahead of print]

PMID:
25716766
2.

Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes.

Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A, Pozzilli P; IMDIAB Group.

PLoS One. 2013;8(2):e56488. doi: 10.1371/journal.pone.0056488. Epub 2013 Feb 20.

3.

Diabetes-related autoantibodies in children with acute lymphoblastic leukemia.

Bizzarri C, Pinto RM, Pitocco D, Astorri E, Cappa M, Hawa M, Giannone G, Palermo A, Maddaloni E, Leslie DR, Pozzilli P; IMDIAB Group.

Diabetes Care. 2012 Mar;35(3):e23. doi: 10.2337/dc11-1946. No abstract available.

4.

Blue eyes as a risk factor for type 1 diabetes.

Di Stasio E, Maggi D, Berardesca E, Marulli GC, Bizzarri C, Lauria A, Portuesi R, Cavallo MG, Costantino F, Buzzetti R, Astorri E, Pitocco D, Songini M, Pozzilli P; IMDIAB Group.

Diabetes Metab Res Rev. 2011 Sep;27(6):609-13. doi: 10.1002/dmrr.1214.

PMID:
21557441
5.

Incidence of type 1 diabetes has doubled in Rome and the Lazio region in the 0- to 14-year age-group: a 6-year prospective study (2004-2009).

Bizzarri C, Patera PI, Arnaldi C, Petrucci S, Bitti ML, Scrocca R, Manfrini S, Portuesi R, Buzzetti R, Cappa M, Pozzilli P; Immunotherapy Diabetes (IMDIAB) Group.

Diabetes Care. 2010 Nov;33(11):e140. doi: 10.2337/dc10-1168. No abstract available.

PMID:
20980419
6.

No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.

Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG, Cappa M, Ghirlanda G, Pozzilli P; IMDIAB Group.

Diabetes Care. 2010 Sep;33(9):1962-3. doi: 10.2337/dc10-0814.

7.

Computer use, free time activities and metabolic control in patients with type 1 diabetes.

Benevento D, Bizzarri C, Pitocco D, Crinò A, Moretti C, Spera S, Tubili C, Costanza F, Maurizi A, Cipolloni L, Cappa M, Pozzilli P; IMDIAB Group.

Diabetes Res Clin Pract. 2010 Jun;88(3):e32-4. doi: 10.1016/j.diabres.2010.03.016. Epub 2010 Apr 7.

PMID:
20378196
8.

The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.

Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R; Immunotherapy Diabetes (IMDIAB) Group.

Diabetes Care. 2008 Jun;31(6):1214-8. doi: 10.2337/dc07-1158. Epub 2008 Feb 5.

PMID:
18252906
9.

Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function.

Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group.

Horm Metab Res. 2008 Jan;40(1):66-8. Epub 2007 Dec 18. No abstract available.

PMID:
18085501
10.

Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis.

Spoletini M, Petrone A, Zampetti S, Capizzi M, Zavarella S, Osborn J, Foffi C, Tuccinardi D, Pozzilli P, Buzzetti R; IMDIAB Group.

Diabet Med. 2007 Dec;24(12):1487-90. Epub 2007 Oct 29.

PMID:
17971177
11.

The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).

Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group.

Diabet Med. 2006 Aug;23(8):920-3.

PMID:
16911633
12.

Raised C-reactive protein levels in patients with recent onset type 1 diabetes.

Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P; IMDIAB Group.

Diabetes Metab Res Rev. 2007 Mar;23(3):211-4.

PMID:
16832831
13.

Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes.

Pozzilli P, Manfrini S, Crinò A, Picardi A, Leomanni C, Cherubini V, Valente L, Khazrai M, Visalli N; IMDIAB group.

Horm Metab Res. 2005 Nov;37(11):680-3.

PMID:
16308836
14.

A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.

Crinó A, Schiaffini R, Ciampalini P, Suraci MC, Manfrini S, Visalli N, Matteoli MC, Patera P, Buzzetti R, Guglielmi C, Spera S, Costanza F, Fioriti E, Pitocco D, Pozzilli P; IMDIAB Group.

J Pediatr Endocrinol Metab. 2005 Aug;18(8):749-54.

PMID:
16200840
15.

Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.

Pozzilli P, Manfrini S, Buzzetti R, Lampeter E, Leeuw ID, Iafusco D, Prisco M, Ionescu-Tirgoviste C, Kolouskovà S, Linn T, Ludvigsson J, Madàcsy L, Mrozikiewicz AS, Mrozikiewicz PM, Podar T, Vavrinec J, Vialettes B, Visalli N, Yilmaz T, Browne PD; IMDIAB group.

Diabetes Res Clin Pract. 2005 Jun;68(3):258-64. Epub 2004 Nov 21.

PMID:
15936469
16.

Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin.

Monetini L, Cavallo MG, Sarugeri E, Sentinelli F, Stefanini L, Bosi E, Thorpe R, Pozzilli P; Immunotherapy Diabetes (IMDIAB) group.

Diabetologia. 2004 Oct;47(10):1795-802. Epub 2004 Oct 22.

PMID:
15502927
17.

A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).

Crinò A, Schiaffini R, Manfrini S, Mesturino C, Visalli N, Beretta Anguissola G, Suraci C, Pitocco D, Spera S, Corbi S, Matteoli MC, Patera IP, Manca Bitti ML, Bizzarri C, Pozzilli P; IMDIAB group.

Eur J Endocrinol. 2004 May;150(5):719-24.

18.

A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8).

Pozzilli P, Crinò A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N, Corbi S, Spera S, Suraci C, Cervoni M, Matteoli MC, Patera IP, Ghirlanda G; IMDIAB Group.

Diabetes Technol Ther. 2003;5(6):965-74.

PMID:
14709198
19.

Environmental risk factors for type 1 diabetes in Rome and province.

Visalli N, Sebastiani L, Adorisio E, Conte A, De Cicco AL, D'Elia R, Manfrini S, Pozzilli P; IMDIAB Group.

Arch Dis Child. 2003 Aug;88(8):695-8.

20.

Antibodies to bovine beta-casein in diabetes and other autoimmune diseases.

Monetini L, Cavallo MG, Manfrini S, Stefanini L, Picarelli A, Di Tola M, Petrone A, Bianchi M, La Presa M, Di Giulio C, Baroni MG, Thorpe R, Walker BK, Pozzilli P; IMDIAB Group.

Horm Metab Res. 2002 Aug;34(8):455-9.

PMID:
12198602
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk